Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ko Yamamoto

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 8, 2024
Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- Insights From the CURRENT AS Registry-2Yuki Obayashi, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Cardiovascular Intervention and Therapeutics|June 22, 2023
In-hospital outcomes after SAVR or TAVI in patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
The American Journal of Cardiology|January 17, 2021
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3)Yukiko Matsumura-Nakano, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Asia|November 22, 2022
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG RegistryKyohei Yamaji, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of Cardiology|June 13, 2024
Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registryKenji Kanenawa, Kyohei Yamaji, Takeshi Morimoto, et al.
Plos One|September 29, 2022
Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3Hiroki Watanabe, Ko Yamamoto, Hiroki Shiomi, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 8, 2024
Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- Insights From the CURRENT AS Registry-2Yuki Obayashi, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Cardiovascular Intervention and Therapeutics|June 22, 2023
In-hospital outcomes after SAVR or TAVI in patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
The American Journal of Cardiology|January 17, 2021
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3)Yukiko Matsumura-Nakano, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Asia|November 22, 2022
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG RegistryKyohei Yamaji, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of Cardiology|June 13, 2024
Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registryKenji Kanenawa, Kyohei Yamaji, Takeshi Morimoto, et al.
Plos One|September 29, 2022
Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3Hiroki Watanabe, Ko Yamamoto, Hiroki Shiomi, et al.
Pageof 10